Orexigen Therapeutics Inc. reported a narrower first-quarter loss and said it is preparing to discuss its experimental obesity drug Contrave with U.S. regulators.
Two key late-stage studies of Pfizer's blockbuster pneumococcal vaccine for children show it works at least as well as a rival in adults, a big market the drugmaker wants to tap.
Atrial fibrillation is the most common cardiac arrhythmia facing physicians, with recent epidemiological studies estimating that there are over 11 million AF sufferers in the seven major economies.
IDBS offers ScienceLink, a scientific content brokerage platform that delivers licensed data, provides on-demand scientific content from third parties, and extends how scientists use this information in their research tools.
Thomson Reuters has launched the Newport Biologics Module, a source of competitive intelligence for biologic and biosimilar drugs.
At a time when many publications are cutting back, Drug Discovery & Development is proud to introduce a special supplement, the 2011 CRO/CMO Directory, the definitive guide to outsourcing services, designed as a handy desk reference to service providers in this growing segment of the drug market.
Moffitt Cancer Center selected Oracle Health Sciences solutions for its health and research informatics platform.
After more than half a dozen years of wrangling, Congress is moving closer to approving the first major update to the U.S. patent system in nearly six decades.
Cephalon, Inc. presented positive results from a Phase 4 trial of nearly 400 people with excessive sleepiness associated with shift work disorder.
A white paper from the Numerical Algorithms Group (NAG), “The Benefits of Using Rigorously Tested Routines from Numerical Libraries” is written to help drug researchers understand how and why to incorporate and use of extensively documented numerical libraries into their application development practices.
Acceleron Pharma, Inc. announced preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.
Advanced microscopic cameras use sophisticated sensors to capture images. New developments in sensors are bringing more features into view.
Multiplex bead-based immunoassays, such as Luminex xMAP technology, allow the simultaneous measurement of multiple analytes using a library of antibodies coupled to color-coded beads.
Symbion Systems, Inc. released the Symbion-DX, Version 2.5, which includes expanded database functionality, instrument control, spectroscopic data processing, and methods development capabilities.
Immunoassays are based on the ability of an antibody to bind with high specificity to a specific antigen molecule, producing a measurable signal that can be used to determine quantitative information of the antigen concentration.